Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CARM1 | Q86X55 | 1/20 | 0.32 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.32 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.32 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24001039 | 0.86 | — | — | |
| SCHEMBL8003665 | 0.72 | CYP1A2 (0.33) | — | |
| SCHEMBL1660122 | 0.70 | CARM1 (0.31) | CARM1PRMT6PRMT1PRMT8 | |
| SCHEMBL14573053 | 0.67 | CARM1 (0.44) | CARM1PRMT6PRMT1PRMT8 | |
| SCHEMBL16491161 | 0.66 | — | — | |
| SCHEMBL1024659 | 0.65 | NCF1 (0.43) | CARM1PRMT6PRMT1PRMT8 | |
| SCHEMBL11641698 | 0.63 | — | — | |
| SCHEMBL11356031 | 0.61 | CYP2C9 (0.59) | — | |
| SCHEMBL13400 | 0.61 | — | — | |
| SCHEMBL20727002 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2708547-B1 | Aqueous solutions of radiometal complexes with tridentate ligends | UNIV ZUERICH (CH) | 2018-06-20 | — | — | EP | claimed |
| EP-2274312-B1 | METAL COMPLEXES | UNIV ZUERICH (CH) | 2015-06-03 | — | — | EP | claimed |
| EP-2708547-A1 | AQUEOUS SOLUTIONS OF RADIOMETAL COMPLEXES WITH TRIDENTATE LIGENDS | Universität Zürich (CH) | 2014-03-19 | — | — | EP | claimed |
| US-20110065680-A1 | Metal Complexes | UNIVERSITY OF ZURICH (CH) | 2011-03-17 | — | — | US | claimed |
| EP-2274312-A2 | METAL COMPLEXES | Universität Zürich (CH) | 2011-01-19 | — | — | EP | claimed |
| WO-2009112823-A2 | METAL COMPLEXES | Universität Zürich (CH) | 2009-09-17 | — | — | WO | claimed |
| US-7122711-B2 | Method for producing biaryl compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-10-17 | — | — | US | claimed |
| US-20030158419-A1 | Method for producing biaryl compound | SUMITOMO CHEMICAL COMPANY, LIMITED | 2003-08-21 | — | — | US | claimed |
| EP-1312605-A1 | Method for producing biaryl compounds | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-05-21 | — | — | EP | claimed |
| EP-2708547-B1 | Aqueous solutions of radiometal complexes with tridentate ligends | UNIV ZUERICH (CH) | 2018-06-20 | — | — | EP | disclosed |
| EP-2274312-B1 | METAL COMPLEXES | UNIV ZUERICH (CH) | 2015-06-03 | — | — | EP | disclosed |
| US-8961924-B2 | Metal complexes | UNIVERSITY OF ZURICH (CH) | 2015-02-24 | — | — | US | disclosed |
| EP-2708547-A1 | AQUEOUS SOLUTIONS OF RADIOMETAL COMPLEXES WITH TRIDENTATE LIGENDS | Universität Zürich (CH) | 2014-03-19 | — | — | EP | disclosed |
| EP-2708547-A1 | AQUEOUS SOLUTIONS OF RADIOMETAL COMPLEXES WITH TRIDENTATE LIGENDS | Universität Zürich (CH) | 2014-03-19 | — | — | EP | disclosed |
| US-20110065680-A1 | Metal Complexes | UNIVERSITY OF ZURICH (CH) | 2011-03-17 | — | — | US | disclosed |
| EP-2274312-A2 | METAL COMPLEXES | Universität Zürich (CH) | 2011-01-19 | — | — | EP | disclosed |
| WO-2009112823-A2 | METAL COMPLEXES | Universität Zürich (CH) | 2009-09-17 | — | — | WO | disclosed |
| US-7122711-B2 | Method for producing biaryl compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-10-17 | — | — | US | disclosed |
| US-20030158419-A1 | Method for producing biaryl compound | SUMITOMO CHEMICAL COMPANY, LIMITED | 2003-08-21 | — | — | US | disclosed |
| EP-1312605-A1 | Method for producing biaryl compounds | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-05-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030158419-A1 | Method for producing biaryl compound | B2M, BMI1, CYP2W1 | CARM1 172/4885PRMT6 1077/4885PRMT1 621/4885 |
| US-20110065680-A1 | Metal Complexes | CLTA, L3MBTL3, CLTB | CARM1 3039/4885PRMT6 1331/4885PRMT1 1865/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.